Author: CO-COMMUNICATIONS

Posted Date:

April 15, 2026

Re:Cognition Health Delivers Landmark International Clinical Trial to Explore Whether a Simple Finger-prick Blood-based Biomarker Test Can Provide Earlier Alzheimer’s Diagnosis

CO-COMMUNICATIONS

April 15, 2026
Inc. Names Re:Cognition Health Co-Founder and CEO Dr. Emer MacSweeney to Its 2026 Female Founders 500 List

CO-COMMUNICATIONS

March 18, 2026
Merri Jo Cowen Transitions from Stellar MLS CEO Role to Lead Growth of UCO

CO-COMMUNICATIONS

March 11, 2026
Stellar MLS Names Longtime Executive Shayne Fairley CEO

CO-COMMUNICATIONS

March 3, 2026
SLC100: Sarah Lawrence College Celebrates 100 Years of Empowering Curious and Creative Lifelong Learners

CO-COMMUNICATIONS

January 27, 2026
Re:Cognition Health Announces Medicare Coverage for FDA-Approved Early-Stage Alzheimer’s Disease Treatments at Its Four U.S. Clinics

CO-COMMUNICATIONS

January 27, 2026